Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures

Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The decision comes as ARPA-H launches…

Submit Your Paper to GMJ

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.

Even modest sleep loss triggers weight gain in high-risk adults, new trial data show

A pooled analysis of two randomized trials found that reducing sleep by just 1.5 hours per night is associated with…

Short sleep duration linked to weight gain and reduced activity in six-week study

Researchers at Columbia University Vagelos College of Physicians and Surgeons found that reducing sleep by 80 minutes per night for…

New Molecular Diagnostic Kit Offers Rapid Detection for Multiple Arboviruses

A new molecular diagnostic kit developed by Fiocruz enables rapid simultaneous detection of multiple arboviruses including dengue, Zika, and chikungunya—reducing…

The Kent MenB Lesson: Why Bacterial Recombination Demands a New Paradigm in Meningococcal Surveillance

Horizontal gene transfer enabled the Kent meningitis B outbreak strain to acquire hypervirulence from commensal bacteria. This revelation demands urgent…

Ketamine Bladder Syndrome in Adolescents: A Call for Urgent International Surveillance and Clinical Preparedness

Ketamine bladder syndrome in adolescents reveals critical gaps in drug harm surveillance. Healthcare systems must establish international surveillance networks and…

NHS Mandates 3-Week Appointment Notice to End Last-Minute Scheduling Chaos

England's NHS will mandate at least three weeks' advance notice for all new planned appointments, addressing longstanding patient communication failures.…

Low-dose CT screening in car parks detects early-stage lung cancer in asymptomatic patients

A mobile CT screening unit in a Banbury supermarket car park detected early-stage lung cancer in an asymptomatic patient, raising…

Light-Activated Molecular Switch Reawakens Dormant Cancer Cells, ETH Zurich Study Shows

ETH Zurich scientists have engineered a light-controlled molecular switch that selectively destroys stress hormone receptors in dormant cancer cells, potentially…

GMJ BriefsView all →
© 2026 GMJ News · PHIG · Sheni Network